Island Setting Receives Improved Clinical Laboratory Diagnostics
|
By LabMedica International staff writers Posted on 13 Jul 2009 |
A testing system is helping to improve efficiency in a hospital laboratory on the Isle of Guernsey.
The new system benefits both staff and patients. Previously, different platforms meant multiple blood draws--one serum tube for each of the analyzers, usually three to four per patient-to obtain results as quickly as possible. The new workflow makes the phlebotomist's work easier and means less discomfort for the patient.
Two cobas 6000 analyzers linked to modular preanalytics from Roche (Burgess Hill, UK) are helping the laboratory at Princess Elizabeth Hospital (St Martins, Guernsey BCD) increase efficiency and become more self-sufficient.
"Although [we are] a small isolated lab, we try to do as much as possible ourselves. We were dealing with an escalating number of tests and when the time came to upgrade four aging analyzers in our clinical chemistry department, consolidation seemed an obvious solution," explained Nigel Turner, section head of clinical chemistry at the hospital. With 183 different assays, Roche offers tests on an automated serum work area (SWA) platform, thus providing an ideal solution for the Guernsey laboratory.
As the lab runs a multidisciplinary on-call system, people from various fields including hematology or histology are also required to run the analyzers outside normal core hours. Now, it is just one blood tube, one analyzer.
Roche Diagnostics helps health professionals detect, monitor, and manage the patient's medical condition more effectively.
Related Links:
Roche
Princess Elizabeth Hospital
The new system benefits both staff and patients. Previously, different platforms meant multiple blood draws--one serum tube for each of the analyzers, usually three to four per patient-to obtain results as quickly as possible. The new workflow makes the phlebotomist's work easier and means less discomfort for the patient.
Two cobas 6000 analyzers linked to modular preanalytics from Roche (Burgess Hill, UK) are helping the laboratory at Princess Elizabeth Hospital (St Martins, Guernsey BCD) increase efficiency and become more self-sufficient.
"Although [we are] a small isolated lab, we try to do as much as possible ourselves. We were dealing with an escalating number of tests and when the time came to upgrade four aging analyzers in our clinical chemistry department, consolidation seemed an obvious solution," explained Nigel Turner, section head of clinical chemistry at the hospital. With 183 different assays, Roche offers tests on an automated serum work area (SWA) platform, thus providing an ideal solution for the Guernsey laboratory.
As the lab runs a multidisciplinary on-call system, people from various fields including hematology or histology are also required to run the analyzers outside normal core hours. Now, it is just one blood tube, one analyzer.
Roche Diagnostics helps health professionals detect, monitor, and manage the patient's medical condition more effectively.
Related Links:
Roche
Princess Elizabeth Hospital
Latest Hematology News
- Next-Generation Hematology Platform Streamlines High-Complexity Lab Workflows
- Blood Eosinophil Count May Predict Cancer Immunotherapy Response and Toxicity
- Higher Ferritin Threshold May Improve Iron Deficiency Detection in Children
- Stem Cell Biomarkers May Guide Precision Treatment in Acute Myeloid Leukemia
- Advanced CBC-Derived Indices Integrated into Hematology Platforms
- Blood Test Enables Early Detection of Multiple Myeloma Relapse
- Single Assay Enables Rapid HLA and ABO Genotyping for Transplant Matching
- Prognostic Biomarker Identified in Diffuse Large B-Cell Lymphoma
- Routine Blood Test Parameters Link Anemia to Cancer Risk and Mortality
- Prognostic Tool Guides Personalized Treatment in Rare Blood Cancer
- New Platelet Function Assay Enables Monitoring of Antiplatelet Therapy
- Open Multi-Omics Platform Identifies Prognostic Subtypes in Blood Cancers
- AI-Powered Digital Workflow Standardizes Bone Marrow Aspirate Morphology
- Rapid Cartridge-Based Test Aims to Expand Access to Hemoglobin Disorder Diagnosis
- New Guidelines Aim to Improve AL Amyloidosis Diagnosis
- Automated Hemostasis System Helps Labs of All Sizes Optimize Workflow
Channels
Clinical Chemistry
view channel
Saliva-Based Test Detects Biochemical Signs of Sleep Loss
Acute sleep loss impairs cognition and motor skills, raising safety risks that resemble alcohol intoxication. Clinicians currently lack an objective biochemical test to determine when someone is dangerously... Read more
Simple Dual-Tau Blood Test Detects and Stages Alzheimer’s Disease
Alzheimer’s disease is typically confirmed and staged with positron emission tomography scans and cerebrospinal fluid testing, procedures that are costly and invasive. Broader access to minimally invasive... Read more
Alzheimer’s Blood Biomarkers Linked to Early Cognitive Differences Before Dementia
Blood-based screening for Alzheimer’s disease offers a noninvasive, lower-cost alternative to brain imaging or spinal fluid testing, yet its ability to flag the earliest cognitive changes has been unclear.... Read moreMolecular Diagnostics
view channel
New PCR Assay Supports Bundibugyo Ebola Outbreak Surveillance
Rapid identification of Ebola infections is essential to limit transmission and guide public health response, yet detection can be difficult when outbreaks involve rare variants. The current outbreaks... Read more
Plasma Protein Signature Predicts Lung Cancer Risk Up to Five Years Ahead
Lung cancer remains a leading cause of cancer death, and many cases are detected only after symptoms appear. Current screening programs largely target people with a history of smoking, leaving other at-risk... Read moreHematology
view channel
Next-Generation Hematology Platform Streamlines High-Complexity Lab Workflows
Sysmex America (Chicago, IL, USA) has introduced the next generation XR-Series, centered on the XR-10 Automated Hematology Module for high-complexity laboratories. The platform builds on the widely used... Read more
Blood Eosinophil Count May Predict Cancer Immunotherapy Response and Toxicity
Immune checkpoint inhibitors have improved outcomes across many cancers, yet only a subset of patients derive durable benefit and biomarkers to guide treatment remain limited. Eosinophils, best known for... Read moreImmunology
view channelAptamer-Based Biosensor Enables Mutation-Resilient SARS-CoV-2 Detection
Rapid evolution of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can undermine existing molecular diagnostics, especially when assays target small viral components. Double-antibody sandwich... Read more
Study Points to Autoimmune Pathway Behind Long COVID Symptoms
Long COVID leaves many SARS-CoV-2 survivors with persistent fatigue, cognitive issues, palpitations, and musculoskeletal pain for months or years. Estimates cited in new research suggest 4%–20% of infected... Read more
Metabolic Biomarker Distinguishes Latent from Active Tuberculosis and Tracks Treatment Response
Tuberculosis (TB) remains the world’s leading infectious killer, with 10.8 million cases and 1.25 million deaths recorded globally in 2023. Yet many infected individuals never develop active disease, underscoring... Read moreMicrobiology
view channel
New Culture Medium Speeds C. difficile Resistance Detection and Reduces Costs
Clostridioides difficile infections remain a persistent threat in hospitals and communities, affecting about 500,000 people in the United States each year. Severe cases can be fatal within 30 days of diagnosis,... Read more
Automated Blood Culture System Speeds Detection of Bloodstream Infections
Bloodstream infections and sepsis require rapid laboratory detection to guide targeted antimicrobial therapy and reduce mortality. Conventional blood culture workflows can delay actionable results by critical... Read morePathology
view channel
3D Spatial Multi-Omics Maps Intra-Tumor Diversity in Colorectal Cancer
Colorectal cancer remains a leading cause of cancer death, and clinical decision-making is complicated by marked intra-tumor heterogeneity. Conventional bulk sequencing averages molecular signals across... Read more
Blood-Based Method Tracks Gene Activity in the Living Brain
Real-time measurement of gene activity in the brain has been limited by assays requiring destructive tissue sampling. Tracking active genes could reveal how the body responds to environmental factors,... Read moreIndustry
view channel
Collaboration Advances ctDNA-Guided Development in Metastatic Colorectal Cancer
Natera, Inc. (Austin, TX, USA) and CytoDyn Inc. (Vancouver, WA, USA) announced a strategic collaboration focused on metastatic colorectal cancer (mCRC). Under the agreement, Natera will evaluate circulating... Read more








